Guo, G., Wang, Y., Zhang, Y., Chen, X., Lu, J., Wang, H., . . . Xia, L. (2019). Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data. World J Gastroenterol.
Chicago Style CitationGuo, Gui-Fang, Yi-Xing Wang, Yi-Jun Zhang, Xiu-Xing Chen, Jia-Bin Lu, Hao-Hua Wang, Chang Jiang, Hui-Quan Qiu, i Liang-Ping Xia. "Predictive and Prognostic Implications of 4E-BP1, Beclin-1, and LC3 for Cetuximab Treatment Combined With Chemotherapy in Advanced Colorectal Cancer With Wild-type KRAS: Analysis From Real-world Data." World J Gastroenterol 2019.
Cita MLAGuo, Gui-Fang, et al. "Predictive and Prognostic Implications of 4E-BP1, Beclin-1, and LC3 for Cetuximab Treatment Combined With Chemotherapy in Advanced Colorectal Cancer With Wild-type KRAS: Analysis From Real-world Data." World J Gastroenterol 2019.